Literature DB >> 5309476

Protection against Hong Kong influneza by adjuvant vaccine containing A2-Ann Arbor-67.

T C Eickhoff, G Meiklejohn.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 5309476      PMCID： PMC2427759     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  6 in total

Review 1.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

2.  Trials of aqueous killed influenza vaccine in Canada, 1968-69.

Authors:  M C Williams; L Davignon; J C McDonald; P V Pavilanis; A Boudreault; A J Clayton
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

3.  Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

Authors:  Matthew R Sandbulte; Gretchen S Jimenez; Adrianus C M Boon; Larry R Smith; John J Treanor; Richard J Webby
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

Review 4.  Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine.

Authors:  Luca T Giurgea; David M Morens; Jeffery K Taubenberger; Matthew J Memoli
Journal:  Vaccines (Basel)       Date:  2020-07-23

Review 5.  Towards a sane and rational approach to management of Influenza H1N1 2009.

Authors:  William R Gallaher
Journal:  Virol J       Date:  2009-05-07       Impact factor: 4.099

6.  Influenza pandemics of the 20th century.

Authors:  Edwin D Kilbourne
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.